Lfcr investors have opportunity to lead lifecore biomedical, inc. securities fraud lawsuit with the schall law firm

Los angeles , sept. 3, 2024 /prnewswire/ -- the schall law firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against lifecore biomedical, inc. ("lifecore" or "the company") (nasdaq: lfcr) for violations of §§10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission.
LFCR Ratings Summary
LFCR Quant Ranking